DPW Holdings invests $1M in Sandstone Diagnostics
DPW Holdings announced that it has provided, through a preferred investment with certain privileges and rights, $1M to Sandstone Diagnostic. This investment represents a 4.05% equity stake in the innovative developer of point-of care medical testing equipment and systems. Sandstone is the creator of Trak, www.trakfertility.com, the leading male fertility tracker which has been clinically tested and is FDA cleared for distribution. Trak is a consumer test kit and mobile app for males that provides couples a simple and accurate way to monitor and improve his fertility from the comfort and privacy of their home. Trak utilizes its proprietary bio-analysis platform to empower men to take control of their reproductive health and improve a couple's chances of conception. Sandstone Diagnostics is a Bay Area consumer health company focused on leveraging innovative biotechnologies to develop instruments and consumables for point-of-care medical testing that empower people to measure and improve important health markers at home.